Phase I/II Study of Treg/Tcon Addback to Partially Matched Related Donor Stem Cells With Myeloablative Conditioning and Post-transplant Cyclophosphamide for High Risk Hematologic Malignancies

NCT01818479 · clinicaltrials.gov ↗
PHASE1
Phase
TERMINATED
Status
10
Enrollment
OTHER
Sponsor class

Stopped Trial discontinued prior to starting Phase II portion due to low accrual.

Conditions

Interventions

Sponsor

University of Utah